Cleo Diagnostics Ltd (cov) Logo

Cleo Diagnostics Ltd (COV)

___:___ · Healthcare
ASX Delayed
Cboe Live

What is live streaming pricing?

Stock prices will auto-update without reloading the page. How it works:

  • Flashing prices signify an increase (green) or decrease (red) from previous price. Otherwise, price is unchanged.
  • Expect a short delay while pricing data initially loads.
  • Note, prices only update during market hours (10am-4:13pm AEST).

More about Cboe Live pricing.

OK, got it



Cleo Diagnostics Limited (COV) (Cleo, or the Company) is bringing to market a simple blood test for the accurate and early diagnosis of ovarian cancer, using its novel patented CXCL10 biomarker. Cleo's first test - AdnexaSureTM is designed to distinguish benign from malignant growths and will be compatible with standard diagnostic laboratory workflows worldwide.

Share Price Activity (ASX)

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume (4w avg)
Day Range -
Prev Close
Last Trade


1 Week
1 Month
2024 YTD
1 Year
vs Sector (1yr) -
vs ASX 200 (1yr) -22.61%


Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 1,748 of 2,381
Sector Rank 168 of 227

Key Fundamentals

Shares Issued
Sector Healthcare
Similar Companies AVE / ADR / TRP
EPS -$0.083
DPS $0.00
Book Value Per Share -$0.011

Broker Consensus

COV is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.


Price Sensitive only

Corporate Overview

Corporate Details

Head Office Melbourne VIC 3000
Registry XCEND
Auditor BDO Audit Pty Ltd
Date Listed 22 Aug 2023

Upcoming Calendar (Forecasted)

Date Event
29/08/2024 Report (Prelim)
25/09/2024 Report (Annual)
27/02/2025 Report (Interim)

Former Company Names

  • Cleo Diagnostics Ltd has no former company names.

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management



Director Interests

The current holdings of COV directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Andrew Stephens 27/09/2023 N/A 500,000 1,500,000 N/A
Lucinda Nolan 27/09/2023 N/A N/A 1,500,000 N/A
Richard Allman 27/09/2023 1,500,000 N/A 2,500,000 N/A
Thomas Jobling 27/09/2023 1,000,000 250,000 1,500,000 N/A
Adrien Wing 27/09/2023 N/A 14,250,000 N/A N/A

Shareholder Info

Top 20 Shareholders

Data supplied by Morningstar and accurate on Aug 17, 2023.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
Loumea Investment Pty Ltd 7,625,000 5.93%
Hudson Institute Investment Holdings Pty Ltd 7,500,000 5.84%
Michelle Wing 6,500,000 5.06%
Wing Investment Holdings Pty Ltd 6,500,000 5.06%
Natalie Patterson 3,000,000 2.33%
Zen Innovations Pty Ltd 3,000,000 2.33%
Clinton Carey 2,125,000 1.65%
Eduardo Vom 2,000,000 1.56%
Jawaf Enterprises Pty Ltd 2,000,000 1.56%
Hardy Road Investments Pty Ltd 1,812,500 1.41%
Dc & Pc Holdings Pty Ltd <Dc & Pc Neesham Super A/C> 1,750,000 1.36%
Vision Tech Nominees Pty Ltd 1,615,000 1.26%
Ogg Pty Ltd 1,500,000 1.17%
Richard Allman 1,500,000 1.17%
Richard Vom 1,500,000 1.17%
Citicorp Nominees Pty Limited 1,375,000 1.07%
Joseph Patrick Burke 1,250,000 0.97%
Wing Investment Holdings Pty Ltd <Wing Family A/C> 1,250,000 0.97%
Apnea Holdings Pty Ltd <Kelly Family A/C> 1,200,000 0.93%
Brett Wing 1,200,000 0.93%

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 7 110 83 393 194 787

Substantial Shareholders

A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.

Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.

Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.

Name Last Notice Total Shares Shares Held (%)
Hudson Institute Investment Holdings Pty Ltd 31/07/2023 7,500,000 5.84
Richard Vom 31/07/2023 9,475,000 7.37
Michelle Wing 31/07/2023 14,250,000 11.09

Shareholders Buying

12 month transaction history compiled from ASX announcements.

No buy transactions reported by Substantial Shareholders in the past 12 months.

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
No Financial Year End data available
COV Historical Price Data (CSV)
Up to 20 years of EOD share price history

Important note:

All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)

Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.